Table 1.
Patients’ demographics among the study periods.
Table 2.
Examples of clinical pharmacy interventions and description of the probability of avoided adverse drug events.
Table 3.
Cost saving, added cost, and cost avoidance associated with each category of clinical pharmacist intervention during the study period.
Fig 1.
Total benefit probability curve over 3-month period (deterministic sensitivity analysis).
Fig 2.
Total benefit probability curve over 1-year period (deterministic sensitivity analysis).
Fig 3.
Total benefit probability curve over 3-month period (probabilistic sensitivity analysis).
Fig 4.
Total benefit probability curve over 1-year period (probabilistic sensitivity analysis).
Fig 5.
A regression tornado diagram of elements and their effect on the outcome.
Table 4.
Outcomes of sensitivity analysis with their uncertainty distributions.